Our business is built around improving the lives of our patients, but critical to our long-term success is our focus on having a positive impact on our employees, communities, stockholders, and the environment.
Formal oversight of ESG matters is the responsibility of the Nominating and Corporate Governance Committee of the Board of Directors. The General Counsel and Assistant General Counsel serve as executive sponsors to coordinate the development of our ESG programs with input from key management leaders and subject matter experts across the organization.
To reinforce our ongoing commitment to acting responsibly and sustainably, we established a working group of internal leaders to execute the highest priority ESG factors for our business and to develop a strategy aligned with our long-term corporate goals. In Q4 of 2022, we engaged Ernst & Young to conduct an ESG Priority Assessment to identify, refine, and assess the most important and relevant ESG topics to our business and our stakeholders in order to inform company strategy, targets, risk management, and reporting.
Our ESG strategy includes four distinct pillars around building a sustainable and responsible enterprise focused on providing extraordinary care that changes lives. The results of our ESG Priority Assessment will inform goal-setting and tracking key metrics as we mature our ESG program.